The cells were washed twice with PBS at 4°C and lysed on ice in RIPA lysis buffer containing 50 mM tris(hydroxymethyl) aminomethane (Tris)–HCl, pH 7.4, 1% NP-40, 150 mM NaCl, 0.25% Na-deoxycholate, 1 mM Na3VO4, and 1 mM NaF and 2 mM phenylmethylsulfonyl fluoride, 2 mM EDTA, 10 µg/mL pepstatin, and 10 µg/mL leupeptin. The lysates were centrifuged at 12,000 rpm for 20 min at 4°C, and then the supernatants were collected for bicinchoninic acid protein assay. Total proteins (30 µg) were separated by 12% sodium dodecyl sulfate–polyacrylamide gel electrophoresis and then transferred to polyvinylidene fluoride membrane. The membranes were incubated with primary antibodies for cleaved PARP, Bcl-2, Mcl-1, Bcl-xl, c-FLIP, CIAP1, XIAP, p53, NQO1, and β-actin, which were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA), at 4°C overnight, washed, and then incubated with horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology) at 37°C for 1 h. The membranes were washed and detected using enhanced chemiluminescence detection system according to the manufacturer’s protocols.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.